AI in Oncology Market - 2025-2033
AI in Oncology Market reached US$ 2.43 Billion in 2024 and is expected to reach US$ 22.85 Billion by 2033, growing with a CAGR of 25.30% during the forecast period 2026-2033.
The AI in Oncology Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A AI in Oncology Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Component Type
Both primary and secondary data sources have been used in the global AI in Oncology Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
The AI in Oncology Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A AI in Oncology Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Component Type
- Software*
- Hardware
- Services
- Breast Cancer*
- Lung Cancer
- Prostate Cancer
- Skin Cancer
- Others
- Cancer Detection*
- Drug Discovery
- Drug Development
- Others
- Hospitals*
- Pharmaceutical Companies
- Research Institutes
- Others
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Go-to-market Strategy.
- Neutral perspective on the market performance.
- Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
- Customized regional/country reports as per request and country level analysis.
- Potential & niche segments and regions exhibiting promising growth covered.
- Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Both primary and secondary data sources have been used in the global AI in Oncology Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS
3.1. Key Trends and Future Projections
4. SNIPPET BY COMPONENT TYPE
5. SNIPPET BY CANCER TYPE
5.1. Snippet by Application
5.2. Snippet by End User
5.3. Snippet by Region
6. DYNAMICS
6.1. Impacting Factors
6.1.1. Drivers
6.1.1.1. Advancements in AI and Machine Learning
6.1.1.2. Increasing Cancer Incidence
6.1.2. Restraints
6.1.2.1. High Cost of AI Systems
6.1.2.2. Data Privacy and Security Concerns
6.1.2.3. XX
6.1.3. Opportunity
6.1.3.1. Tele-oncology and Remote Monitoring
6.1.3.2. XX
6.1.4. Impact Analysis
7. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
7.1. Market Leaders and Pioneers
7.1.1. Emerging Pioneers and Prominent Players
7.1.2. Established Leaders with Largest Marketing Brand
7.1.3. Market Leaders with Established Products
7.2. Latest Developments and Breakthroughs
7.3. Regulatory and Reimbursement Landscape
7.3.1. North America
7.3.2. Europe
7.3.3. Asia Pacific
7.3.4. Latin America
7.3.5. Middle East & Africa
7.4. Porter’s Five Forces Analysis
7.5. Supply Chain Analysis
7.6. Patent Analysis
7.7. SWOT Analysis
7.8. Pipeline Analysis
7.9. Epidemiology Analysis
7.10. Unmet Needs and Gaps
7.11. Recommended Strategies for Market Entry and Expansion
7.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
7.13. Pricing Analysis and Price Dynamics
7.14. Key Opinion Leaders
8. AI IN ONCOLOGY MARKET COMPONENT TYPE OUTLOOK
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
8.1.2. Market Attractiveness Index, By Component Type
8.2. Software*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Hardware
8.4. Services
9. AI IN ONCOLOGY MARKET CANCER TYPE OUTLOOK
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
9.1.2. Market Attractiveness Index, By Cancer Type
9.2. Breast Cancer*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Lung Cancer
9.4. Prostate Cancer
9.5. Skin Cancer
9.6. Others
10. AI IN ONCOLOGY MARKET APPLICATION OUTLOOK
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.1.2. Market Attractiveness Index, By Application
10.2. Cancer Detection*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Drug Discovery
10.4. Drug Development
10.5. Others
11. AI IN ONCOLOGY MARKET END USER OUTLOOK
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.2. Market Attractiveness Index, By End User
11.2. Hospitals*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Pharmaceutical Companies
11.4. Research Institutes
11.5. Others
12. AI IN ONCOLOGY MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
13. INTRODUCTION
13.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
13.1.1. Market Attractiveness Index, By Region
13.2. North America
13.2.1. Introduction
13.2.2. Key Region-Specific Dynamics
13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.2.7.1. U.S.
13.2.7.2. Canada
13.2.7.3. Mexico
13.3. Europe
13.3.1. Introduction
13.3.2. Key Region-Specific Dynamics
13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.3.7.1. Germany
13.3.7.2. UK
13.3.7.3. France
13.3.7.4. Spain
13.3.7.5. Italy
13.3.7.6. Rest of Europe
13.4. Asia-Pacific
13.4.1. Introduction
13.4.2. Key Region-Specific Dynamics
13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.4.7.1. China
13.4.7.2. India
13.4.7.3. Japan
13.4.7.4. South Korea
13.4.7.5. Rest of Asia-Pacific
13.5. South America
13.5.1. Introduction
13.5.2. Key Region-Specific Dynamics
13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.5.7.1. Brazil
13.5.7.2. Argentina
13.5.7.3. Rest of South America
13.6. Middle East and Africa
13.6.1. Introduction
13.6.2. Key Region-Specific Dynamics
13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
14. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
15. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS
15.1. Market Share Analysis and Positioning Matrix
15.2. Strategic Partnerships, Mergers & Acquisitions
15.3. Key Developments in Product Portfolios and Innovations
15.4. Company Benchmarking
16. COMPANY PROFILES
Key Players
1. AZRA AL*
1.1. Company Overview
1.1.1. Product Portfolio
1.1.1.1. Product Description
1.1.1.2. Product Key Performance Indicators (KPIs)
1.1.1.3. Historic and Forecasted Product Sales
1.1.1.4. Product Sales Volume
2. FINANCIAL OVERVIEW
2.1. Company Revenue
2.1.1. Geographical Revenue Shares
2.1.1.1. Revenue Forecasts
2.1.2. Key Developments
2.1.2.1. Mergers & Acquisitions
2.1.2.2. Key Product Development Activities
2.1.2.3. Regulatory Approvals, etc.
2.1.3. SWOT Analysis
2.2. CureMetrix, Inc.
2.3. ConcertAI
2.4. Immunai
2.5. MVision AI Inc.
2.6. Paige AI, Inc.
2.7. Mindpeak GmbH
2.8. Imagene AI Ltd.
2.9. Predictive Oncology
2.10. Tempus
Emerging Players
1. INSILICO MEDICINE
LIST NOT EXHAUSTIVE
1. ASSUMPTIONS AND RESEARCH METHODOLOGY
1.1. Data Collection Methods
1.2. Data Triangulation
1.3. Forecasting Techniques
1.4. Data Verification and Validation
2. APPENDIX
2.1. About Us and Services
2.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS
3.1. Key Trends and Future Projections
4. SNIPPET BY COMPONENT TYPE
5. SNIPPET BY CANCER TYPE
5.1. Snippet by Application
5.2. Snippet by End User
5.3. Snippet by Region
6. DYNAMICS
6.1. Impacting Factors
6.1.1. Drivers
6.1.1.1. Advancements in AI and Machine Learning
6.1.1.2. Increasing Cancer Incidence
6.1.2. Restraints
6.1.2.1. High Cost of AI Systems
6.1.2.2. Data Privacy and Security Concerns
6.1.2.3. XX
6.1.3. Opportunity
6.1.3.1. Tele-oncology and Remote Monitoring
6.1.3.2. XX
6.1.4. Impact Analysis
7. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
7.1. Market Leaders and Pioneers
7.1.1. Emerging Pioneers and Prominent Players
7.1.2. Established Leaders with Largest Marketing Brand
7.1.3. Market Leaders with Established Products
7.2. Latest Developments and Breakthroughs
7.3. Regulatory and Reimbursement Landscape
7.3.1. North America
7.3.2. Europe
7.3.3. Asia Pacific
7.3.4. Latin America
7.3.5. Middle East & Africa
7.4. Porter’s Five Forces Analysis
7.5. Supply Chain Analysis
7.6. Patent Analysis
7.7. SWOT Analysis
7.8. Pipeline Analysis
7.9. Epidemiology Analysis
7.10. Unmet Needs and Gaps
7.11. Recommended Strategies for Market Entry and Expansion
7.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
7.13. Pricing Analysis and Price Dynamics
7.14. Key Opinion Leaders
8. AI IN ONCOLOGY MARKET COMPONENT TYPE OUTLOOK
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
8.1.2. Market Attractiveness Index, By Component Type
8.2. Software*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Hardware
8.4. Services
9. AI IN ONCOLOGY MARKET CANCER TYPE OUTLOOK
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
9.1.2. Market Attractiveness Index, By Cancer Type
9.2. Breast Cancer*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Lung Cancer
9.4. Prostate Cancer
9.5. Skin Cancer
9.6. Others
10. AI IN ONCOLOGY MARKET APPLICATION OUTLOOK
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.1.2. Market Attractiveness Index, By Application
10.2. Cancer Detection*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Drug Discovery
10.4. Drug Development
10.5. Others
11. AI IN ONCOLOGY MARKET END USER OUTLOOK
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.2. Market Attractiveness Index, By End User
11.2. Hospitals*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Pharmaceutical Companies
11.4. Research Institutes
11.5. Others
12. AI IN ONCOLOGY MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
13. INTRODUCTION
13.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
13.1.1. Market Attractiveness Index, By Region
13.2. North America
13.2.1. Introduction
13.2.2. Key Region-Specific Dynamics
13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.2.7.1. U.S.
13.2.7.2. Canada
13.2.7.3. Mexico
13.3. Europe
13.3.1. Introduction
13.3.2. Key Region-Specific Dynamics
13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.3.7.1. Germany
13.3.7.2. UK
13.3.7.3. France
13.3.7.4. Spain
13.3.7.5. Italy
13.3.7.6. Rest of Europe
13.4. Asia-Pacific
13.4.1. Introduction
13.4.2. Key Region-Specific Dynamics
13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.4.7.1. China
13.4.7.2. India
13.4.7.3. Japan
13.4.7.4. South Korea
13.4.7.5. Rest of Asia-Pacific
13.5. South America
13.5.1. Introduction
13.5.2. Key Region-Specific Dynamics
13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.5.7.1. Brazil
13.5.7.2. Argentina
13.5.7.3. Rest of South America
13.6. Middle East and Africa
13.6.1. Introduction
13.6.2. Key Region-Specific Dynamics
13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component Type
13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cancer Type
13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
14. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
15. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS
15.1. Market Share Analysis and Positioning Matrix
15.2. Strategic Partnerships, Mergers & Acquisitions
15.3. Key Developments in Product Portfolios and Innovations
15.4. Company Benchmarking
16. COMPANY PROFILES
Key Players
1. AZRA AL*
1.1. Company Overview
1.1.1. Product Portfolio
1.1.1.1. Product Description
1.1.1.2. Product Key Performance Indicators (KPIs)
1.1.1.3. Historic and Forecasted Product Sales
1.1.1.4. Product Sales Volume
2. FINANCIAL OVERVIEW
2.1. Company Revenue
2.1.1. Geographical Revenue Shares
2.1.1.1. Revenue Forecasts
2.1.2. Key Developments
2.1.2.1. Mergers & Acquisitions
2.1.2.2. Key Product Development Activities
2.1.2.3. Regulatory Approvals, etc.
2.1.3. SWOT Analysis
2.2. CureMetrix, Inc.
2.3. ConcertAI
2.4. Immunai
2.5. MVision AI Inc.
2.6. Paige AI, Inc.
2.7. Mindpeak GmbH
2.8. Imagene AI Ltd.
2.9. Predictive Oncology
2.10. Tempus
Emerging Players
1. INSILICO MEDICINE
LIST NOT EXHAUSTIVE
1. ASSUMPTIONS AND RESEARCH METHODOLOGY
1.1. Data Collection Methods
1.2. Data Triangulation
1.3. Forecasting Techniques
1.4. Data Verification and Validation
2. APPENDIX
2.1. About Us and Services
2.2. Contact Us
